A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Quantification of Immunostained Caspase-9 in Retinal Tissue

1.6K views

⸱

DOI:

10.3791/64237

⸱

July 25th, 2022

 ,  ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

Presented here is a detailed immunohistochemistry protocol to identify, validate, and target functionally relevant caspases in complex tissues.

Abstract

The family of caspases is known to mediate many cellular pathways beyond cell death, including cell differentiation, axonal pathfinding, and proliferation. Since the identification of the family of cell death proteases, there has been a search for tools to identify and expand the function of specific family members in development, health, and disease states. However, many of the currently commercially available caspase tools that are widely used are not specific for the targeted caspase. In this report, we delineate the approach we have used to identify, validate, and target caspase-9 in the nervous system using a novel inhibitor and genetic approaches with immunohistochemical read-outs. Specifically, we used the retinal neuronal tissue as a model to identify and validate the presence and function of caspases. This approach enables the interrogation of cell-type specific apoptotic and non-apoptotic caspase-9 functions and can be applied to other complex tissues and caspases of interest. Understanding the functions of caspases can help to expand current knowledge in cell biology, and can also be advantageous to identify potential therapeutic targets due to their involvement in disease.

Introduction

The caspases are a family of proteases that regulate developmental cell death, immune responses, and aberrant cell death in disease1,2. While it is well known that members of the caspase family are induced in a variety of neurodegenerative diseases, understanding which caspase drives disease pathology is more challenging3. Such studies require tools to identify, characterize, and validate the function of individual caspase family members. Parsing out the relevant individual caspases is important both from a mechanistic and a therapeutic standpoint, as the literature has multiple studies....

Access restricted. Please log in or start a trial to view this content.

Protocol

This protocol follows the Association for Research in Vision and Ophthalmology (ARVO) statement for the use of animals in ophthalmic and vision research. Rodent experiments were approved and monitored by the Institutional Animal Care and Use Committee (IACUC) of Columbia University.

1. Preparation of retinal tissue and cryosectioning

  1. Euthanize the animals by administration of intraperitoneal anesthesia (ketamine (80-100 mg/kg) and xylazine (5-10 mg/kg)), and perfuse the mice subjected to RVO (see8 for details) with 4% paraformaldehyde (PFA) using a peristaltic pump.
    NOTE: Toe-pinch....

Access restricted. Please log in or start a trial to view this content.

Results

The described protocol allows the user to analyze and quantify caspase-9 levels in the retinal tissue. Additionally, it present tools to further identify, validate, and specifically target caspase-9 and downstream substrates. The summarized steps allow quantifiable analysis of caspase levels and cellular specificity in fluorescent photomicrographs. All figures show representative photomicrographs and quantification of the indicated caspase levels in the total retina, endothelial cells, and neurons in uninjured and 1-day .......

Access restricted. Please log in or start a trial to view this content.

Discussion

Caspases are a multi-membered family of proteases best studied for their roles in cell death and inflammation; however, more recently a variety of non-death functions have been uncovered for some family members4,5. Much of our understanding of caspase function is derived from work in cell culture and from inferential data from human disease. While it is appreciated that there is aberrant induction, activation, or inactivation of caspases in disease, it has been c.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare the following competing interests: C.M.T. has the following patent applications US20200164026, US20190142915, and US20150165061. C.M.T. and S.S. have a patent application US 20140024597. C.M.T., A.M.P., and M.I.A. have a patent application US2020058683. C.M.T. and Y.Y.J. have a patent application WO2018013519. M.I.A and C.M.T are listed as inventors on a patent application WO/2020/223212 by the Trustees of Columbia University in the City of New York. The remaining authors declare no competing interests.

Acknowledgements

This work was supported by the National Science Foundation Graduate Research Fellowship Program (NSF-GRFP) grant DGE - 1644869 and the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH), award number F99NS124180 NIH NINDS Diversity Specialized F99 (to CKCO), the National Eye Institute (NEI) 5T32EY013933 (to AMP), the National Institute of Neurological Disorders and Stroke (RO1 NS081333, R03 NS099920 to CMT), and the Department of Defense Army/Air Force (DURIP to CMT).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
anti-Caspase-7 488Novus BiologicalsNB-56529AF488use at 1:150
anti-cl-Caspase-9Cell Signaling9505-Suse at 1:800
anti-CD31BD Pharmingen553370use at 1:50
Confocal Spinning Disc MicroscopeBiovision
FIJI 2.3.0open source
Fluormount GFisher50-187-88
ForcepRobozRS-5015
iCasp9FL/FL X VECad-CreERT2 micelab generatedsee Avrutsky 2020
Isolectin (594, 649)VectorDL-1207use at 1:200
Ketamine HydrochlorideHenry ScheinNDC: 11695-0702-1
Perfusion pump Masterflex
Pen1-XBir3lab generatedsee Avrutsky 2020
Prism 9.1GraphPad
Tissue-Tek O.C.T.Fisher14-373-65
Vis-a-View 4.0Visitron Systems
XylazineAkornNDCL 59399-110-20

References

  1. Van Opdenbosch, N., Lamkanfi, M. Caspases in cell death, inflammation, and disease. Immunity. 50 (6), 1352-1364 (2019).
  2. Ramirez, M. L. G., Salvesen, G. S. A primer on caspase mechanisms. Seminars in Cell & Developmental Biology. 82, Academic Press. 79-85 (2018).
  3. Troy, C. M., Jean, Y. Y.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Caspase-9 QuantificationImmunohistochemistryConfocal MicroscopyRetinal Vein OcclusionVascular MarkerNeuronal Caspase ExpressionCell Type SpecificityWestern BlottingApoptotic Pathways